Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease

British Journal of Surgery

Volumn 97, Issue 6, 2010, Pages 845-852

  Broeders, J A ^a   Draaisma, W A ^a   Bredenoord, A J ^a   Smout, A J ^a   Broeders, I A ^b   Gooszen, H G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LONG TERM CARE; MALE; MANOMETRY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PH; POSTOPERATIVE CARE; PROSPECTIVE STUDY; QUALITY OF LIFE; STOMACH FUNDOPLICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LONG-TERM CARE; MALE; MANOMETRY; MIDDLE AGED; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952769609     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7023     Document Type: Article

References (53)

1. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180.
2. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920.
3. Jones RH, Hungin APS, Phillips J, Mills JG. Gastro-esophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pratt 1995; 1: 149-154.
4. Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974-979.
5. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am. J Gastroenterol 1999; 94: 1782-1789. (Pubitemid 29315886)
6. Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96(Suppl): S46-S53. (Pubitemid 32758209)
7. Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998; 10: 119-124.
8. Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997; 32: 965-973. (Pubitemid 27433658)
9. Bate CM, Green JR, Axon AT, Murray FE, Tildesley G, Emmas CE et al. Omeprazole is more effective than Cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis. Aliment Pharmacol Ther 1997; 11: 755-763.
10. Hatlebakk JG, Hyggen A, Madsen PH, Walle PO, Schulz T, Mowinckel P et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ 1999; 319: 550-553.
11. Richter JE, Kovacs TO, Greski-Rose PA, Huang B, Fisher R. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther 1999; 13: 795-804. (Pubitemid 29276850)
12. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 656-664. (Pubitemid 39013424)
13. GalmicheJP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997; 11: 765-773.
14. Lauritsen K. Management of endoscopy-negative reflux disease: progress with short-term treatment. Aliment Pharmacol Ther 1997; 11(Suppl 2): 81-85.
15. Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease. Arch Intern Med 2000;160:1803-1809.
16. EI-Serag HB, Sonnenberg A. Outcome of erosive reflux esophagitis after Nissen fundoplication. Am J Gastroenterol 1999; 94: 1771-1776.
17. Hinder RA, Filipi CJ, Wetscher G, Neary P, DeMeester TR, Perdikis G. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994; 220: 472-481.
18. Bammer T, Freeman M, Shahriari A, Hinder RA, DeVault KR, Achem SR. Outcome of laparoscopic antireflux surgery in patients with nonerosive reflux disease. J Gastrointest Surg 2002; 6: 730-737. (Pubitemid 40433492)
19. Desai KM, Frisella MM, Soper NJ. Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis. J Gastrointest Surg 2003; 7:44-51.
20. Gockel I, Heintz A, Domeyer M, Kneist W, Trinh TT, Junginger T. [Nonerosive and erosive gastroesophageal reflux disease. Long-term results of laparoscopic anterior semifundoplication.] Chirurg 2007; 78: 35-39.
21. Watson DI, Foreman D, Devitt PG, Jamieson GG. Preoperative endoscopic grading of esophagitis versus outcome after laparoscopic Nissen fundoplication. Am J Gastroenterol 1997; 92: 222-225.
22. Kamolz T, Granderath FA, Schweiger UM, Pointner R. Laparoscopic Nissen fundoplication in patients with nonerosive reflux disease. Long-term quality-of-life assessment and surgical outcome. Surg Endose 2005; 19: 494-500. (Pubitemid 40897958)
23. Fenton P, Terry ML, Galloway KD, Smith CD, Hunter JG, Waring JP. Is there a role for laparoscopic fundoplication in patients with non-erosive reflux disease (NERD)? Gastroenterology 2000; 118(Suppl 2): A481.
24. Thibault R, Coron E, Sébille V, Sacher-Huvelin S, Bruley D, Gournay J et al. Antireflux surgery for non-erosive and erosive reflux disease in community practice. Aliment Pharmacol Ther 2006; 24: 621-632.
25. Bais JE, Bartelsman JF, Bonjer HJ, Cuesta MA, Go PM, Klinkenberg-Knol EC et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet 2000; 355: 170-174.
26. Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhart-dejong HG, Broeders IA. et al. Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication. Br J Surg 2006; 93:690-697. (Pubitemid 43886020)
27. Draaisma WA, Ruurda JP, Scheffer RC, Simmermacher RK, Gooszen HG, Rijnhart-de Jong HG et al. Randomized clinical trial of standard laparoscopic versus robot-assisted laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease. Br J Surg2006; 93: 1351-1359.
28. Visick AH. A study of the failures after gastrectomy. Ann R Coll Surg Engl 1948; 3: 266-284.
29. Rijnhart-de Jong HG, Draaisma WA, Smout AJ, Broeders IA, Gooszen HG. The Visick score: a good measure for the overall effect of antireflux surgery? Scand J Gastroenterol 2008; 43: 787-793.
30. Velanovich V, Karmy-Jones R. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters. Am Surg 1998; 64:649-653.
31. Zéman Z, Rózsa S, Tihanyi T, Tarkó E. Psychometric documentation of a quality-of-life questionnaire for patients undergoing antireflux surgery (QOLARS). Surg Endosc 2005; 19:257-261. (Pubitemid 40685198)
32. Horbach JM, Masclee AA, Lamers CB, Gooszen HG. Prospective evaluation of 24 hour ambulatory pH metry in Belsey Mark IV antireflux surgery. Gut 1994; 35: 1529-1535.
33. de Boer AG, van Lanschot JJ, Stalmeier PF, van SandickJW, Hulscher JB, de Haes JC et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004; 13: 311-320.
34. Nord E. The validity of a visual analogue scale in determining social utility weights for health states. Int J Health Plann Manage 1991; 6: 234-242.
35. Savary M, Miller G (eds). The Esophagus Handbook and Atlas of Endoscopy. Gassmann: Solothurn, 1978.
36. Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992;87:1102-1111.
37. Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-856.
38. Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 2007; 41: 131-137. (Pubitemid 46148652)
39. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyriläinen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92: 37-41. (Pubitemid 27027025)
40. Kuster E, Ros E, Toledo-Pimentel V, Pujol A, Bordas JM, Grande L et al. Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut 1994; 35: 8-14.
41. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-545.
42. Martínek J, Benes M, Hucl T, Drastich P, Stirand P, Spícak J. Non-erosive and erosive gastroesophageal reflux diseases: no difference with regard to reflux pattern and motility abnormalities. Scand J Gastroenterol 2008; 43: 794-800.
43. Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther 2006; 23: 321-329.
44. Dickman R, Bautista JM, Wong WM, Bhatt R, Beeler JN, Malagon I et al. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. Am J Gastroenterol 2006; 101: 2463-2469.
45. Breumelhof R, Smout AJ, Schyns MW, Bronzwaer PW, Akkermans LM, Jansen A. Prospective evaluation of the effects of Nissen fundoplication on gastroesophageal reflux. Surg Gynecol Obstet 1990; 171: 115-119.
46. Luostarinen M. Nissen fundoplication for reflux esophagitis. Long-term clinical and endoscopic results in 109 of 127 consecutive patients, Ann Surg 1993; 217: 329-337.
47. O'Hanrahan T, Marples M, Bancewicz J. Recurrent reflux and wrap disruption after Nissen fundoplication: detection, incidence and timing. Br J Surg 1990; 7: 545-547.
48. Salminen PT, Hiekkanen HI, Rantala AP, Ovaska JT. Comparison of long-term outcome of laparoscopic and conventional Nissen fundoplication: a prospective randomized study with an 11-year follow-up. Ann Surg 2007; 246:201-206.
49. Broeders JA, Rijnhart-dejong HG, Draaisma WA, Bredenoord AJ, Smout AJ, Gooszen HG. Ten-year outcome of laparoscopic and conventional Nissen fundoplication: randomized clinical trial. Ann Surg 2009; 250: 698-706.
50. Draaisma WA, Rijnhart-dejong HG, Broeders IA, Smout AJ, Furnee EJ, Gooszen HG. Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication: a randomized trial. Ann Surg 2006; 244: 34-41.
51. Jenkinson AD, Kadirkamanathan SS, Scott SM, Yazaki E, Evans DF. Relationship between symptom response and oesophageal acid exposure after medical and surgical treatment for gastro-oesophageal reflux disease. Br J Surg 2004;91:1460-1465. (Pubitemid 39518083)
52. Lord RV, Kaminski A, Oberg S, Bowrey DJ, Hagen JA, DeMeester SR et al. Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg 2002;6:3-9.
53. Catarci M, Gentileschi P, Papi C, Carrara A, Marrese R, Gaspari AL et al. Evidence-based appraisal of antireflux fundoplication. Am Surg 2004; 239: 325-337.